Key facts
- Aspect Analytics’s last known valuation is $14.9M (Sep 2025).
- It has raised $14.0M; the latest was Later Stage VC ($11.7M) in Sep 2025.
- Notable investors include Participatiemaatschappij Vlaanderen, Capricorn Partners, EIT Health, HERAN Partners, KU Leuven — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Aspect Analytics
- ·The full record, as it builds
Funding rounds
No funding rounds for Aspect Analytics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Aspect Analytics
Developer of mass spectrometry imaging software designed to bridge the gap between algorithmic development in bioinformatics research and enterprise-grade software. The company's software designs, implements, and manages optimal software workflows for interdisciplinary teams, which are tailored to a given application's inherent challenges and needs, enabling clients to get large amounts of data to augment mass spectrometry imaging.
- Sector
- Healthcare
- HQ
- Genk, Belgium
- Founded
- 2018
- Employees
- 21
- Website
- aspect-analytics.com/
- Ownership
- Privately Held (backing)
Aspect Analytics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Aspect Analytics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Aspect Analytics in its N-PORT filings yet. We sweep new filings monthly.